Fund Holdings — 5AM Venture Management, LLC

Total Portfolio Value
$360.21M
Total Bought
$8.75M
Total Sold
$73.60M
Net Transaction
-$64.86M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
ERASCA INC(ERAS)5,405,4043,485,971-1,919,43320,10856,40315.66%+36,295
TYRA BIOSCIENCES INC(TYRA)1,029,2981,029,298027,06039,42210.94%+12,362
ENTRADA THERAPEUTICS INC(TRDA)4,056,3794,056,379041,70051,19214.21%+9,492
CENTESSA PHARMACEUTICALS PLC580,945580,945014,52923,0756.41%+8,546
ALX ONCOLOGY HLDGS INC(ALXO)03,057,325+3,057,32506,1301.70%+6,130
TECTONIC THERAPEUTIC INC(TECX)606,660606,660012,65518,7525.21%+6,097
ARTIVA BIOTHERAPEUTICS INC(ARTV)2,353,3042,353,304010,09615,1554.21%+5,060
ZENTALIS PHARMACEUTICALS INC(ZNTL)3,947,9133,947,91305,3309,2382.56%+3,908
MAPLIGHT THERAPEUTICS INC(MPLT)950,011950,011016,68719,3145.36%+2,627
RALLYBIO CORP(RLYB)0291,788+291,78802,6170.73%+2,617
SURROZEN INC(SRZN)387,500387,50008,75811,2883.13%+2,530
CELLDEX THERAPEUTICS INC NEW(CLDX)497,270497,270013,50615,7734.38%+2,268
GH RESEARCH PLC(GHRS)572,665572,66507,2738,0522.24%+779
PHARVARIS N V
COM
797,600797,600022,13322,5326.26%+399
PROTARA THERAPEUTICS INC(TARA)1,369,7821,369,78207,3017,1371.98%-164
SILENCE THERAPEUTICS PLC(SLN)476,200476,20002,8952,5100.70%-386
SKYE BIOSCIENCE INC(SKYE)9,681,7639,681,76307,2585,9501.65%-1,308
BIOHAVEN LTD(BHVN)738,972738,97208,3436,2521.74%-2,091
RALLYBIO CORP(RLYB)3,630,7240-3,630,7242,4910—-2,491
EYEPOINT INC(EYPT)1,050,0001,050,000019,18413,5353.76%-5,649
CAMP4 THERAPEUTICS CORP(CAMP)5,869,0915,869,091035,97825,8837.19%-10,095
ENLIVEN THERAPEUTICS INC772,4770-772,47711,8960—-11,896
VIRIDIAN THERAPEUTICS INC(VRDN)736,5950-736,59522,9230—-22,923
Page 1 of 1
5AM Venture Management, LLC — 13F Holdings — Q1 2026 | TickerTrail